This report from Life Science Intelligence provides the latest market data for the Global Tissue Heart Valves Market. Information covered by this report includes:
This report covers the impact of COVID-19 on tissue heart valve replacement procedures, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Medtronic, Edwards Lifesciences, LivaNova, CryoLife, and others. The report provides insights into trends, drivers, and limiters of the tissue heart valves market, as well as highlights potential opportunities.